Sun Pharma in search of a partner in Japan to market 14 brands: Report

05 May 2016 Evaluate

India’s largest pharmaceutical firm, Sun Pharmaceutical is reportedly scouting for a partner to market 14 brands it acquired from Novartis in Japan. In April, a wholly-owned subsidiary of the company, acquired 14 established prescription brands from Novartis AG and Novartis Pharma AG in Japan, for $293 million.

The acquired brands will be marketed by a local marketing partner under the Sun label. The local marketing partner will also be responsible for distribution of the brands.

Sun Pharmaceutical is the world’s fifth largest specialty generic pharmaceutical company and India’s top pharmaceutical company. Its global presence is supported by 49 manufacturing facilities spread across 6 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities.

Sun Pharma Inds. Share Price

1700.55 0.00 (0.00%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×